For research use only.
Storage
3 years,-20°C,powder
1 years,-80°C,in solvent
In vitro
LMK-235 causes HDAC inhibition with IC50 of <1 μM in human cancer cell lines with different sensitivity towards cisplatin. In breast cancer cell line MDA-MB-231, tongue cancer cell line Cal27, and esophagus cell line Kyse510 cell line, LMK-235 displays a high cytotoxicity, and markedly enhances the cytotoxicity of cisplatin. In addition, LMK-235 also shows nanomolar activity against multiple malaria parasite life cycle stages.